W. Smith
Director/Board Member bei LYRA THERAPEUTICS, INC.
Vermögen: 13 462 $ am 31.03.2024
Profil
Mr. W.
B.
Smith is an Independent Director at eGenesis, Inc. and an Independent Director at Lyra Therapeutics, Inc. He is on the Board of Directors at eGenesis, Inc. and Lyra Therapeutics, Inc. Mr. Smith was previously employed as a Treasurer, Chief Financial & Business Officer by Homology Medicines, Inc., a Chief Financial Officer by Ocular Therapeutix, Inc., a Chief Financial Officer by OmniGuide, Inc., a Chief Financial Officer by NeuroMetrix, Inc., a Chief Financial Officer by SYNARC INC, a Chief Financial Officer by The Virtmed Corp, a Chief Financial Officer by Focal, Inc., a Senior Accountant by Coopers & Lybrand LLP, and a Chief Financial Officer by CytoTherapuetics, Inc. He received his undergraduate degree from Tufts University and an MBA from Peter T Paul College of Business & Economics.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,01% | 17.04.2023 | 790 ( 0,01% ) | 13 462 $ | 31.03.2024 |
LYRA THERAPEUTICS, INC.
-.--% | 01.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von W. Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Director/Board Member | 19.11.2019 |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Director/Board Member | 09.06.2021 |
Ehemalige bekannte Positionen von W. Smith
| Unternehmen | Position | Ende |
|---|---|---|
| Q32 BIO INC. | Director of Finance/CFO | 17.11.2023 |
| OCULAR THERAPEUTIX, INC. | Director of Finance/CFO | 31.03.2017 |
OmniGuide, Inc.
 OmniGuide, Inc. Medical SpecialtiesHealth Technology OmniGuide, Inc. develops advanced energy surgical solutions. It offers gynecology, head and neck, otolaryngology and otology services. The firm also provides enhance surgical accuracy, access and control for minimally invasive surgery, laparoscopy and robotic-assisted surgical products. The was founded by Yoel Fink, John D. Joannopoulos, Edwin L. Thomas and Uri Kolodny in 2000 and is headquartered in Lexington, MA. | Director of Finance/CFO | 01.03.2014 |
| NEUROMETRIX, INC. | Director of Finance/CFO | 30.06.2008 |
Synexus Compass, Inc.
 Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA. | Director of Finance/CFO | 01.02.2005 |
Ausbildung von W. Smith
| Tufts University | Undergraduate Degree |
| Peter T Paul College of Business & Economics | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NEUROMETRIX, INC. | Health Technology |
| OCULAR THERAPEUTIX, INC. | Health Technology |
| LYRA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Focal, Inc.
 Focal, Inc. Chemicals: SpecialtyProcess Industries Focal Inc, is a developing biodegradable interventional therapeutic products to treat serious local diseases. The company products consist of a biodegradable polymer system that can deliver drugs locally to the site of disease and/or act as a physical barrier. Other Focal research & development programs include polymer and drug delivery products to: prevent adhesions (internal scar tissue) following surgery; serve as surgical sealants; and deliver drugs locally for other indications. | Process Industries |
PatientKeeper, Inc.
 PatientKeeper, Inc. Packaged SoftwareTechnology Services PatientKeeper, Inc. provides healthcare applications for physicians. Its clinical solutions include Computerized Physician Order Entry (CPOE), Mobile CPOE, Medication Reconciliation, NoteWriter, Mobile Clinical Results, Physician Portal, ePrescription, Sign-Out, eSignature and Provider Directory. The firm’s financial solutions include PatientKeeper Charge Capture, PatientKeeper Analytics and PatientKeeper PQRS. It operates through its offices located in Boston and Chicago. The company was founded by Stephen Hau and Joseph Vincent Bonventre in 1996 and is headquartered in Boston, MA. | Technology Services |
| Coopers & Lybrand LLP | Commercial Services |
Synexus Compass, Inc.
Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA. | Health Services |
| CytoTherapuetics, Inc. | Finance |
OmniGuide, Inc.
OmniGuide, Inc. Medical SpecialtiesHealth Technology OmniGuide, Inc. develops advanced energy surgical solutions. It offers gynecology, head and neck, otolaryngology and otology services. The firm also provides enhance surgical accuracy, access and control for minimally invasive surgery, laparoscopy and robotic-assisted surgical products. The was founded by Yoel Fink, John D. Joannopoulos, Edwin L. Thomas and Uri Kolodny in 2000 and is headquartered in Lexington, MA. | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Commercial Services |
